Published in Psychosom Med on January 01, 2016
Clinical predictors of depression treatment outcomes in patients with coronary heart disease. J Psychosom Res (2016) 0.75
The Techniques for Overcoming Depression Questionnaire: Mokken Scale Analysis, Reliability, and Concurrent Validity in Depressed Cardiac Patients. Cognit Ther Res (2016) 0.75
Nighttime heart rate predicts response to depression treatment in patients with coronary heart disease. J Affect Disord (2016) 0.75
The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res (1989) 57.78
International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc (2003) 47.83
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med (2000) 18.04
Missing data analysis: making it work in the real world. Annu Rev Psychol (2009) 13.86
Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry (2009) 8.74
Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation (2003) 8.29
Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA (2002) 8.28
Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA (1998) 7.67
Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA (2008) 6.50
C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation (1998) 4.80
Effects of antidepressant treatment following myocardial infarction. Br J Psychiatry (2007) 4.44
Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation (2000) 3.66
Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms. J Psychosom Res (2002) 3.27
Depression as a risk factor for mortality after acute myocardial infarction. Am J Cardiol (2003) 2.87
Depressive disorders and immunity: 20 years of progress and discovery. Brain Behav Immun (2007) 2.75
Assessment of physical activity: an international perspective. Res Q Exerc Sport (2000) 2.63
Insomnia and the risk of acute myocardial infarction: a population study. Circulation (2011) 2.54
Treatment-resistant depression and mortality after acute coronary syndrome. Am J Psychiatry (2009) 2.49
Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine (1997) 2.43
Association of interleukin-6 and other biologic variables with depression in older people living in the community. J Am Geriatr Soc (1999) 2.31
The Depression Interview and Structured Hamilton (DISH): rationale, development, characteristics, and clinical validity. Psychosom Med (2002) 2.22
Exercise for depression. JAMA (2014) 2.18
Psychiatric characteristics associated with long-term mortality among 361 patients having an acute coronary syndrome and major depression: seven-year follow-up of SADHART participants. Arch Gen Psychiatry (2009) 1.92
Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis of 25 years of research. Gen Hosp Psychiatry (2011) 1.85
Moderate exercise improves depression parameters in treatment-resistant patients with major depressive disorder. J Psychiatr Res (2011) 1.80
The longitudinal effects of depression on physical activity. Gen Hosp Psychiatry (2009) 1.71
Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) study. Psychosom Med (2004) 1.64
Nonresponse to treatment for depression following myocardial infarction: association with subsequent cardiac events. Am J Psychiatry (2007) 1.60
Pathways linking depression, adiposity, and inflammatory markers in healthy young adults. Brain Behav Immun (2003) 1.60
Elevated C-reactive protein and homocysteine values: cardiovascular risk factors in hypothyroidism? A cross-sectional and a double-blind, placebo-controlled trial. Atherosclerosis (2003) 1.55
Inflammation and coagulation factors in persons > 65 years of age with symptoms of depression but without evidence of myocardial ischemia. Am J Cardiol (2002) 1.55
Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy. J Psychiatr Res (2006) 1.46
Sertraline safety and efficacy in major depression: a double-blind fixed-dose comparison with placebo. Biol Psychiatry (1995) 1.46
The thyroid-brain interaction in thyroid disorders and mood disorders. J Neuroendocrinol (2008) 1.43
Relation of depressive symptoms to C-reactive protein and pathogen burden (cytomegalovirus, herpes simplex virus, Epstein-Barr virus) in patients with earlier acute coronary syndromes. Am J Cardiol (2005) 1.43
Impact of cardiac rehabilitation on depression and its associated mortality. Am J Med (2007) 1.42
Association between increased mortality and mild thyroid dysfunction in cardiac patients. Arch Intern Med (2007) 1.40
Subclinical hypothyroidism and the risk of coronary heart disease: a meta-analysis. Am J Med (2006) 1.32
Pretreatment REM sleep and subjective sleep quality distinguish depressed psychotherapy remitters and nonremitters. Biol Psychiatry (1999) 1.25
The antidepressant effect of sertraline is not enhanced by dose titration: results from an outpatient clinical trial. Int Clin Psychopharmacol (2001) 1.21
Coronary heart disease and depression: a review of recent mechanistic research. Can J Psychiatry (2006) 1.21
Characteristics of depression remission and its relation with cardiovascular outcome among patients with chronic heart failure (from the SADHART-CHF Study). Am J Cardiol (2011) 1.21
Depressive symptoms, physical inactivity and risk of cardiovascular mortality in older adults: the Cardiovascular Health Study. Heart (2011) 1.19
Insomnia and objectively measured sleep disturbances predict treatment outcome in depressed patients treated with psychotherapy or psychotherapy-pharmacotherapy combinations. J Clin Psychiatry (2011) 1.17
Role of depression and inflammation in incident coronary heart disease events. Am J Cardiol (2005) 1.13
Sleep and treatment response in depression: new findings using power spectral analysis. Psychiatry Res (2001) 1.08
Treatment-resistant depression: definitions, review of the evidence, and algorithmic approach. J Affect Disord (2013) 1.06
Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness. Biol Psychiatry (1997) 1.03
Relation between C reactive protein and depression remission status in patients presenting with acute coronary syndrome. Heart (2006) 0.95
Cynical hostility, depressive symptoms, and the expression of inflammatory risk markers for coronary heart disease. J Behav Med (2003) 0.92
Effect of smoking and sedentary behavior on the association between depressive symptoms and mortality from coronary heart disease. Am J Cardiol (2003) 0.92
Thyroid function and the natural history of depression: findings from the Caerphilly Prospective Study (CaPS) and a meta-analysis. Clin Endocrinol (Oxf) (2008) 0.91
Obstructive sleep apnea/hypopnea syndrome and poor response to sertraline in patients with coronary heart disease. J Clin Psychiatry (2011) 0.89
The impact of lifestyle factors on the 2-year course of depressive and/or anxiety disorders. J Affect Disord (2014) 0.89
Evaluation of autonomic activity in patients with subclinical hypothyroidism. J Endocrinol Invest (2005) 0.87
Antidepressants do not improve event-free survival in patients with heart failure when depressive symptoms remain. Heart Lung (2013) 0.82
Inflammation and treatment response to sertraline in patients with coronary heart disease and comorbid major depression. J Psychosom Res (2011) 0.81
Depression and thyroid axis function in coronary artery disease: impact of cardiac impairment and gender. Clin Cardiol (2006) 0.80
Depression and self-reported functional status: impact on mortality following acute myocardial infarction. J Eval Clin Pract (2010) 0.79
Depression treatment for patients with complex conditions. JAMA (2012) 0.76
Warfarin and aspirin in patients with heart failure and sinus rhythm. N Engl J Med (2012) 6.60
The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation (2006) 6.58
Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial. Eur Heart J (2005) 4.37
Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol (2004) 4.14
Centralized, stepped, patient preference-based treatment for patients with post-acute coronary syndrome depression: CODIACS vanguard randomized controlled trial. JAMA Intern Med (2013) 3.65
Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial. Circulation (2006) 3.40
Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J (2004) 3.37
Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms. J Psychosom Res (2002) 3.27
Implantable cardiac device procedures in older patients: use and in-hospital outcomes. Arch Intern Med (2010) 3.05
Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF). Am Heart J (2006) 3.05
Impact of oxypurinol in patients with symptomatic heart failure. Results of the OPT-CHF study. J Am Coll Cardiol (2008) 2.89
Depression as a risk factor for mortality after acute myocardial infarction. Am J Cardiol (2003) 2.87
TNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle. FASEB J (2005) 2.81
Clinical depression and inflammatory risk markers for coronary heart disease. Am J Cardiol (2002) 2.67
Mitral valve surgery in heart failure: insights from the Acorn Clinical Trial. J Thorac Cardiovasc Surg (2006) 2.62
Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study. Am J Cardiol (2006) 2.58
Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association. Circulation (2014) 2.50
Treatment-resistant depression and mortality after acute coronary syndrome. Am J Psychiatry (2009) 2.49
The prognostic importance of different definitions of worsening renal function in congestive heart failure. J Card Fail (2002) 2.45
Prevalence of anxiety in adults with diabetes: a systematic review. J Psychosom Res (2002) 2.41
Depression, the autonomic nervous system, and coronary heart disease. Psychosom Med (2005) 2.36
Mental stress-induced ischemia and all-cause mortality in patients with coronary artery disease: Results from the Psychophysiological Investigations of Myocardial Ischemia study. Circulation (2002) 2.32
Antidepressant drug compliance: reduced risk of MI and mortality in depressed patients. Am J Med (2011) 2.29
Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era. Ann Thorac Surg (2010) 2.23
Prediction of mode of death in heart failure: the Seattle Heart Failure Model. Circulation (2007) 2.22
Increased myocardial gene expression of tumor necrosis factor-alpha and nitric oxide synthase-2: a potential mechanism for depressed myocardial function in hibernating myocardium in humans. Circulation (2002) 2.11
What works in chronic care management: the case of heart failure. Health Aff (Millwood) (2009) 2.11
Death takes a raincheck. Psychosom Med (2004) 2.10
Heart failure guidelines, performance measures, and the practice of medicine: mind the gap. J Am Coll Cardiol (2010) 2.06
A pivotal role for endogenous TGF-beta-activated kinase-1 in the LKB1/AMP-activated protein kinase energy-sensor pathway. Proc Natl Acad Sci U S A (2006) 2.03
Anxiety and poor glycemic control: a meta-analytic review of the literature. Int J Psychiatry Med (2002) 2.02
ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Circulation (2011) 1.97
Assessment and treatment of depression in patients with cardiovascular disease: National Heart, Lung, and Blood Institute Working Group Report. Psychosom Med (2006) 1.96
Depression, mortality, and medical morbidity in patients with coronary heart disease. Biol Psychiatry (2003) 1.96
The emerging role of microRNAs in cardiac remodeling and heart failure. Circ Res (2008) 1.94
Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial. JAMA (2009) 1.79
Deep RNA sequencing reveals dynamic regulation of myocardial noncoding RNAs in failing human heart and remodeling with mechanical circulatory support. Circulation (2014) 1.76
TNF provokes cardiomyocyte apoptosis and cardiac remodeling through activation of multiple cell death pathways. J Clin Invest (2007) 1.75
Prevalence of depression in hospitalized patients with congestive heart failure. Psychosom Med (2003) 1.75
Atrial fibrillation in the elderly. Am J Med (2007) 1.74
Circulating levels of tumor necrosis factor correlate with indexes of depressed heart rate variability: a study in patients with mild-to-moderate heart failure. Chest (2003) 1.73
Depression in patients with coronary heart disease. Am J Med (2008) 1.73
Aligning quality and payment for heart failure care: defining the challenges. J Card Fail (2003) 1.71
The selection and design of control conditions for randomized controlled trials of psychological interventions. Psychother Psychosom (2009) 1.70
Low heart rate variability and the effect of depression on post-myocardial infarction mortality. Arch Intern Med (2005) 1.70
In search of new therapeutic targets and strategies for heart failure: recent advances in basic science. Lancet (2011) 1.69
Cardiac care for older adults. Time for a new paradigm. J Am Coll Cardiol (2011) 1.69
Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials. J Am Coll Cardiol (2003) 1.67
History of depression and survival after acute myocardial infarction. Psychosom Med (2009) 1.65
Proapoptotic effects of caspase-1/interleukin-converting enzyme dominate in myocardial ischemia. Circ Res (2005) 1.64
Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) study. Psychosom Med (2004) 1.64
Medical disorders among patients admitted to a public-sector psychiatric inpatient unit. Psychiatr Serv (2002) 1.61
Incidence of intracranial hemorrhage in patients with atrial fibrillation who are prone to fall. Am J Med (2005) 1.61
Pathways linking depression, adiposity, and inflammatory markers in healthy young adults. Brain Behav Immun (2003) 1.60
Effects of phosphodiesterase type 5 inhibition on systemic and pulmonary hemodynamics and ventricular function in patients with severe symptomatic aortic stenosis. Circulation (2012) 1.56
Escherichia coli LPS-induced LV dysfunction: role of toll-like receptor-4 in the adult heart. Am J Physiol Heart Circ Physiol (2002) 1.48
Advanced heart failure and transplant cardiology: a subspecialty is born. J Am Coll Cardiol (2009) 1.48
Sertraline for prevention of depression recurrence in diabetes mellitus: a randomized, double-blind, placebo-controlled trial. Arch Gen Psychiatry (2006) 1.45
Mitochondrial tolerance to stress impaired in failing heart. J Mol Cell Cardiol (2003) 1.45
Relation of depressive symptoms to C-reactive protein and pathogen burden (cytomegalovirus, herpes simplex virus, Epstein-Barr virus) in patients with earlier acute coronary syndromes. Am J Cardiol (2005) 1.43
Toll-like receptor 2 modulates left ventricular function following ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol (2006) 1.43
Clinical and Echocardiographic Factors Associated With New-Onset Atrial Fibrillation in Heart Failure - Subanalysis of the WARCEF Trial. Circ J (2016) 1.43
The Great Debate, revisited. Psychosom Med (2006) 1.42
Body mass index and mortality in acute myocardial infarction patients. Am J Med (2012) 1.42
Extracellular matrix remodeling following myocardial injury. Ann Med (2003) 1.41
Aspects of social support associated with depression at hospitalization and follow-up assessment among cardiac patients. J Cardiopulm Rehabil (2003) 1.41
Rationale and study design of the increase of vagal tone in heart failure study: INOVATE-HF. Am Heart J (2012) 1.41
Heterogeneous effects of tissue inhibitors of matrix metalloproteinases on cardiac fibroblasts. Am J Physiol Heart Circ Physiol (2005) 1.40
Cellular remodeling in heart failure disrupts K(ATP) channel-dependent stress tolerance. EMBO J (2003) 1.40
Treatment of depression after coronary artery bypass surgery: a randomized controlled trial. Arch Gen Psychiatry (2009) 1.40
Biomarkers of inflammation in heart failure. Heart Fail Rev (2010) 1.40
Guidelines, performance measures, and the practice of medicine: mind the gap. J Card Fail (2010) 1.37
Prescription opioid analgesics increase the risk of depression. J Gen Intern Med (2013) 1.37
Telephone-based coping skills training for patients awaiting lung transplantation. J Consult Clin Psychol (2006) 1.33
Anxiety disorders increase risk for incident myocardial infarction in depressed and nondepressed Veterans Administration patients. Am Heart J (2010) 1.27
Cardiac myocyte apoptosis provokes adverse cardiac remodeling in transgenic mice with targeted TNF overexpression. Am J Physiol Heart Circ Physiol (2004) 1.24
Age disparities in heart failure research. JAMA (2010) 1.23
Experimental and clinical basis for the use of statins in patients with ischemic and nonischemic cardiomyopathy. J Am Coll Cardiol (2008) 1.23
CD14-deficient mice are protected against lipopolysaccharide-induced cardiac inflammation and left ventricular dysfunction. Circulation (2002) 1.22
Renin-angiotensin inhibition in systolic heart failure and chronic kidney disease. Am J Med (2012) 1.22
Role of microRNAs in cardiac remodeling and heart failure. Cardiovasc Drugs Ther (2011) 1.21
Coronary heart disease and depression: a review of recent mechanistic research. Can J Psychiatry (2006) 1.21
Extracellular matrix turnover and inflammatory markers independently predict functional status and outcome in chronic heart failure. J Card Fail (2008) 1.20
Predictors of mortality in younger and older patients with heart failure and preserved or reduced left ventricular ejection fraction. Am Heart J (2003) 1.19
Diabetic cardiomyopathy: bench to bedside. Heart Fail Clin (2012) 1.19
Nuclear factor-kappaB protects the adult cardiac myocyte against ischemia-induced apoptosis in a murine model of acute myocardial infarction. Circulation (2003) 1.18
Genetic variation in the B-type natiuretic peptide pathway affects BNP levels. Cardiovasc Drugs Ther (2007) 1.18